Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: PLASMODIUM, MALÁRIA
ABNT
SILVINO, Ana Carolina Rios et al. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, v. 64, n. 5, p. 1-14 art. e02056-19, 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02056-19. Acesso em: 04 set. 2024.APA
Silvino, A. C. R., Kano, F. S., Costa, M. A., Fontes, C. J. F., Soares, I. da S., Brito, C. F. A. de, et al. (2020). Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, 64( 5), 1-14 art. e02056-19. doi:10.1128/AAC.02056-19NLM
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 set. 04 ] Available from: https://doi.org/10.1128/AAC.02056-19Vancouver
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 set. 04 ] Available from: https://doi.org/10.1128/AAC.02056-19